Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy — Éric Deutsch (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
Shared by
Guido Guido Kroemer
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
Article
2019
en
Authors
+1 more
ÉD
Éric Deutsch
CC
Cyrus Chargari
LG
Lorenzo Galluzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
Z Ortiz
,
Beverley Shea
,
María E. Suarez‐Almazor
,
David Moher
,
G A Wells
,
Peter Tugwell
Letter
2018
Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacy
Jonathan Pol
,
Guido Guido Kroemer
Article
1993
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria
Sanjeev Krishna
,
Feiko O. ter Kuile
,
Wichai Supanaranond
,
Sasithon Pukrittayakamee
,
Paktiya Teja‐Isavadharm
,
Dennis E. Kyle
,
Sir Nicholas White
British Journal of Clinical Pharmacology
Chapter in a book
2012
Antibiotics in aquaculture: reducing their use and maintaining their efficacy
Pete Smith
Article
2014
Impact of myeloid cells on the efficacy of anticancer chemotherapy
Laura Senovilla
,
Fernando Aranda
,
Lorenzo Galluzzi
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.